SAB Biotherapeutics SABS
NASDAQ SABS
$3.04 -0.07 (-2.25%)
As of: Nov 12, 2026 · 10:49 AM EST

SAB Biotherapeutics (SABS) Income Taxes Paid (2021 - 2026)

Updated

Analysis

SAB Biotherapeutics (SABS) Income Taxes Paid (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes Paid (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -4.69 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 426.00 Mn
10 SAB Biotherapeutics 279.79 Mn -130.87 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -143.00
Mar 31, 2026 775,143.00
Dec 31, 2025 191.00
Jun 30, 2025 -191.00
Mar 31, 2025 2.42 Mn
Dec 31, 2022 -39,459.00
Dec 31, 2021 244,505.00
API Access

SAB Biotherapeutics Income Taxes Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-taxes-paid&ticker=SABS&period=max&api_key=YOUR_API_KEY